Diagnostic performance of <sup>18</sup> F-FDG-PET/CT in inflammation of unknown origin: A clinical series of 317 patients.

Holubar, Jan; Broner, Jonathan; Arnaud, Erik; Hallé, Olivier; Mura, Thibault; Chambert, Benjamin; Sotto, Albert; Roubille, Camille et al. · J Intern Med · 2022

case_series · Level IV

Where this comes from

Abstract

Inflammation of unknown origin (IUO) is a challenging situation in internal medicine. To describe the final diagnoses in IUO and assess the helpfulness of <sup>18</sup> F-fluorodesoxyglucose positron emission tomography with computerized tomography (<sup>18</sup> F-FDG-PET/CT) in the diagnosis strategy. A total of 317 IUO patients with <sup>18</sup> F-FDG-PET/CT were enrolled. A diagnosis was reached in 228 patients: noninfectious inflammatory diseases (NIID) (37.5%), infectious diseases (18.6%), malignancies (7.9%), and non-systemic-inflammatory miscellaneous diseases (7.9%). The two leading causes of NIID were polymyalgia rheumatica and giant cell arteritis. <sup>18</sup> F-FDG-PET/CT results were classified as true positive in 49.8% of patients and contributory in 75.1% of overall IUO patients (after the complete investigation set and a prolonged follow-up). In multivariate analysis, only C-reactive protein minimum level (≥50 mg/L) was associated with the contributory status of <sup>18</sup> F-FDG-PET/CT. Within the wide spectrum of IUO underlying diseases, <sup>18</sup> F-FDG-PET/CT is helpful to make a diagnosis and to eliminate inflammatory diseases. Obese patients constitute a specific group needing further studies.

Medical subject headings